19 results
8-K
EQ
Equillium Inc
1 Apr 24
Other Events
8:05am
in the Phase 3 AURORA1 study of voclosporin (ORR 70% at 6 and 12 months in active treatment).
Consistent with the decline in UPCR overtime, subjects
8-K
EX-99.1
EQ
Equillium Inc
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
. If you are an Employee eligible for overtime compensation under the Fair Labor Standards Act of 1938, as amended (that is, a “Non-Exempt Employee
8-K
EX-99.1
EQ
Equillium Inc
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
months in active treatment).
Consistent with the decline in UPCR overtime, subjects were able to taper their systemic corticosteroids over the course
424B3
EQ
Equillium Inc
10 Nov 22
Prospectus supplement
4:13pm
and other compensation, overtime, meal and rest break requirements, classification of employees as exempt or non-exempt and classification of workers
S-4/A
v1nc am68
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
oiz 83cp8xuegmpx
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
qny8e bjb
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
ysi vi5ab0ta9n
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-10.1
tj396vc
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am
S-8
EX-99.2
2q3vo10xlf0 sg0t
16 Oct 18
Registration of securities for employees
4:31pm
DRS
EX-10.11
mqb2jpay
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.12
cldakwn
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.2
pr1xk ghyec
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.10
mwbxhdd 78ss64u
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.9
3im gmvvg5w23dbnn5r
3 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next